"Actually, why do I always spend the St Nicholas holiday in the US, instead of with my family", I asked myself when I boarded the plane to the USA on 4 Dec 2009, in anticipation of a long 16 hour trip to the USA, hiding for days in the dungeons of a large convention center. However, from a patient perspective, it was again worth it. Year by year, more than 20.000 hematologists and healthcare people attend the annual meeting of the American Society of Hematology. All top experts from the CML space are presenting their research here, competing for the hottest piece of news from clinical trials.
Launched in December 2009 the Emerging Regions Support and Partnership (ERSAP) Preceptorship Program is a unique opportunity for clinicians from developing countries who treat Chronic Myeloid Leukemia (CML) to undertake an intensive educational program to develop and expand their CML management skills. Hematologists from Argentina, India and Madagascar now undertake the first preceptorships supported by the iCMLf.
Patient groups are uniquely placed to challenge fears and misperceptions that hamper prevention and contribute to late diagnoses, poor treatment and the social isolation of patients. Acting locally but using the Internet they are now campaigning globally. A recent article in "Cancerworld" also features the activities of The Max Foundation. See the article here.
On 25 February 2010, the Oncology Times reported about the launch of the International CML Foundation (25 February 2010, Volume 32, Issue 4, pp 24-26, doi: 10.1097/01.COT.0000368857.22447.27). See the full text article here.
The newly formed International Chronic Myeloid Leukemia Foundation (iCMLf) has launched the Emerging Regions Support and Partnership (ERSAP) program at the annual meeting of the American Society of Hematology (ASH). The ERSAP Preceptorship Project will commence in 2010, providing training, education and support for 30 clinicians in emerging countries each year.